FGF Regulates TGF-β Signaling and Endothelial-to-Mesenchymal Transition via Control of let-7 miRNA Expression

Cell Reports

Volumn 2, Issue 6, 2012, Pages 1684-1696

  Chen, Pei Yu ^a   Qin, Lingfeng ^a   Barnes, Carmen ^b,g   Charisse, Klaus ^b   Yi, Tai ^a   Zhang, Xinbo ^a   Ali, Rahmat ^a   Medina, Pedro P ^c   Yu, Jun ^a   Slack, Frank J ^c   Anderson, Daniel G ^d,e   Kotelianski, Victor ^d   Wang, Fen ^f   Tellides, George ^a   Simons, Michael ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ALNYLAM PHARMACEUTICALS   (United States)

^c YALE UNIVERSITY   (United States)

^d Massachusetts Institute of Technology Cambridge   (United States)

^e MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^f TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

^g Celgene Avilomics Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR; LET 7 MICRORNA; LIGAND; MICRORNA; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERY DISEASE; ARTICLE; BLOOD VESSEL FUNCTION; CELL TRANSFORMATION; CONTROLLED STUDY; EMBRYO; ENDOTHELIAL TO MESENCHYMAL TRANSITION; ENDOTHELIUM; GENE EXPRESSION REGULATION; GRAFT REJECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; INFLAMMATION; INTIMA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALS; DISEASE MODELS, ANIMAL; ENDOTHELIUM; FIBROBLAST GROWTH FACTORS; GENE EXPRESSION REGULATION; HUMANS; MICE; MICE, INBRED BALB C; MICE, TRANSGENIC; MICRORNAS; NEOINTIMA; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA; VASCULITIS;

ANIMALIA; MURINAE;

EID: 84871676561     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2012.10.021     Document Type: Article

References (39)

1. Acevedo L., Yu J., Erdjument-Bromage H., Miao R.Q., Kim J.E., Fulton D., Tempst P., Strittmatter S.M., Sessa W.C. A new role for Nogo as a regulator of vascular remodeling. Nat. Med. 2004, 10:382-388.
2. Basile D.P., Friedrich J.L., Spahic J., Knipe N., Mang H., Leonard E.C., Changizi-Ashtiyani S., Bacallao R.L., Molitoris B.A., Sutton T.A. Impaired endothelial proliferation and mesenchymal transition contribute to vascular rarefaction following acute kidney injury. Am. J. Physiol. Renal Physiol. 2011, 300:F721-F733.
3. Chang A.C., Fu Y., Garside V.C., Niessen K., Chang L., Fuller M., Setiadi A., Smrz J., Kyle A., Minchinton A., et al. Notch initiates the endothelial-to-mesenchymal transition in the atrioventricular canal through autocrine activation of soluble guanylyl cyclase. Dev. Cell 2011, 21:288-300.
4. Chen P.Y., Simons M., Friesel R. FRS2 via fibroblast growth factor receptor 1 is required for platelet-derived growth factor receptor beta-mediated regulation of vascular smooth muscle marker gene expression. J. Biol. Chem. 2009, 284:15980-15992.
5. Costa M.A., Simon D.I. Molecular basis of restenosis and drug-eluting stents. Circulation 2005, 111:2257-2273.
6. Eswarakumar V.P., Lax I., Schlessinger J. Cellular signaling by fibroblast growth factor receptors. Cytokine Growth Factor Rev. 2005, 16:139-149.
7. Fafeur V., Terman B.I., Blum J., Böhlen P. Basic FGF treatment of endothelial cells down-regulates the 85-KDa TGF beta receptor subtype and decreases the growth inhibitory response to TGF-beta 1. Growth Factors 1990, 3:237-245.
8. Filipowicz W., Bhattacharyya S.N., Sonenberg N. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?. Nat. Rev. Genet. 2008, 9:102-114.
9. Friesel R., Komoriya A., Maciag T. Inhibition of endothelial cell proliferation by gamma-interferon. J. Cell Biol. 1987, 104:689-696.
10. Garcia J., Sandi M.J., Cordelier P., Binétruy B., Pouysségur J., Iovanna J.L., Tournaire R. Tie1 deficiency induces endothelial-mesenchymal transition. EMBO Rep. 2012, 13:431-439.
11. Ghosh A.K., Bradham W.S., Gleaves L.A., De Taeye B., Murphy S.B., Covington J.W., Vaughan D.E. Genetic deficiency of plasminogen activator inhibitor-1 promotes cardiac fibrosis in aged mice: involvement of constitutive transforming growth factor-beta signaling and endothelial-to-mesenchymal transition. Circulation 2010, 122:1200-1209.
12. Gotoh N., Ito M., Yamamoto S., Yoshino I., Song N., Wang Y., Lax I., Schlessinger J., Shibuya M., Lang R.A. Tyrosine phosphorylation sites on FRS2alpha responsible for Shp2 recruitment are critical for induction of lens and retina. Proc. Natl. Acad. Sci. USA 2004, 101:17144-17149.
13. Hagan J.P., Piskounova E., Gregory R.I. Lin28 recruits the TUTase Zcchc11 to inhibit let-7 maturation in mouse embryonic stem cells. Nat. Struct. Mol. Biol. 2009, 16:1021-1025.
14. Hatanaka K., Simons M., Murakami M. Phosphorylation of VE-cadherin controls endothelial phenotypes via p120-catenin coupling and Rac1 activation. Am. J. Physiol. Heart Circ. Physiol. 2011, 300:H162-H172.
15. Johnson C.D., Esquela-Kerscher A., Stefani G., Byrom M., Kelnar K., Ovcharenko D., Wilson M., Wang X., Shelton J., Shingara J., et al. The let-7 microRNA represses cell proliferation pathways in human cells. Cancer Res. 2007, 67:7713-7722.
16. Khurana R., Zhuang Z., Bhardwaj S., Murakami M., De Muinck E., Yla-Herttuala S., Ferrara N., Martin J.F., Zachary I., Simons M. Angiogenesis-dependent and independent phases of intimal hyperplasia. Circulation 2004, 110:2436-2443.
17. Kitao A., Sato Y., Sawada-Kitamura S., Harada K., Sasaki M., Morikawa H., Shiomi S., Honda M., Matsui O., Nakanuma Y. Endothelial to mesenchymal transition via transforming growth factor-beta1/Smad activation is associated with portal venous stenosis in idiopathic portal hypertension. Am. J. Pathol. 2009, 175:616-626.
18. Krützfeldt J., Rajewsky N., Braich R., Rajeev K.G., Tuschl T., Manoharan M., Stoffel M. Silencing of microRNAs in vivo with 'antagomirs'. Nature 2005, 438:685-689.
19. Lehrbach N.J., Armisen J., Lightfoot H.L., Murfitt K.J., Bugaut A., Balasubramanian S., Miska E.A. LIN-28 and the poly(U) polymerase PUP-2 regulate let-7 microRNA processing in Caenorhabditis elegans. Nat. Struct. Mol. Biol. 2009, 16:1016-1020.
20. Li Y., VandenBoom T.G., Kong D., Wang Z., Ali S., Philip P.A., Sarkar F.H. Up-regulation of miR-200 and let-7 by natural agents leads to the reversal of epithelial-to-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells. Cancer Res. 2009, 69:6704-6712.
21. Lin Y., Zhang J., Zhang Y., Wang F. Generation of an Frs2alpha conditional null allele. Genesis 2007, 45:554-559.
22. Love K.T., Mahon K.P., Levins C.G., Whitehead K.A., Querbes W., Dorkin J.R., Qin J., Cantley W., Qin L.L., Racie T., et al. Lipid-like materials for low-dose, in vivo gene silencing. Proc. Natl. Acad. Sci. USA 2010, 107:1864-1869.
23. Maller Schulman B.R., Liang X., Stahlhut C., DelConte C., Stefani G., Slack F.J. The let-7 microRNA target gene, Mlin41/Trim71 is required for mouse embryonic survival and neural tube closure. Cell Cycle 2008, 7:3935-3942.
24. Medici D., Potenta S., Kalluri R. Transforming growth factor-β2 promotes Snail-mediated endothelial-mesenchymal transition through convergence of Smad-dependent and Smad-independent signalling. Biochem. J. 2011, 437:515-520.
25. Michlewski G., Cáceres J.F. Antagonistic role of hnRNP A1 and KSRP in the regulation of let-7a biogenesis. Nat. Struct. Mol. Biol. 2010, 17:1011-1018.
26. Murakami M., Nguyen L.T., Zhuang Z.W., Moodie K.L., Carmeliet P., Stan R.V., Simons M. The FGF system has a key role in regulating vascular integrity. J. Clin. Invest. 2008, 118:3355-3366.
27. Murakami M., Nguyen L.T., Hatanaka K., Schachterle W., Chen P.Y., Zhuang Z.W., Black B.L., Simons M. FGF-dependent regulation of VEGF receptor 2 expression in mice. J. Clin. Invest. 2011, 121:2668-2678.
28. Ohtani K., Egashira K., Hiasa K., Zhao Q., Kitamoto S., Ishibashi M., Usui M., Inoue S., Yonemitsu Y., Sueishi K., et al. Blockade of vascular endothelial growth factor suppresses experimental restenosis after intraluminal injury by inhibiting recruitment of monocyte lineage cells. Circulation 2004, 110:2444-2452.
29. Papetti M., Shujath J., Riley K.N., Herman I.M. FGF-2 antagonizes the TGF-beta1-mediated induction of pericyte alpha-smooth muscle actin expression: a role for myf-5 and Smad-mediated signaling pathways. Invest. Ophthalmol. Vis. Sci. 2003, 44:4994-5005.
30. Ramos C., Becerril C., Montaño M., García-De-Alba C., Ramírez R., Checa M., Pardo A., Selman M. FGF-1 reverts epithelial-mesenchymal transition induced by TGF-beta1 through MAPK/ERK kinase pathway. Am. J. Physiol. Lung Cell. Mol. Physiol. 2010, 299:L222-L231.
31. Rao D.A., Eid R.E., Qin L., Yi T., Kirkiles-Smith N.C., Tellides G., Pober J.S. Interleukin (IL)-1 promotes allogeneic T cell intimal infiltration and IL-17 production in a model of human artery rejection. J. Exp. Med. 2008, 205:3145-3158.
32. Reinhart B.J., Slack F.J., Basson M., Pasquinelli A.E., Bettinger J.C., Rougvie A.E., Horvitz H.R., Ruvkun G. The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature 2000, 403:901-906.
33. Roush S., Slack F.J. The let-7 family of microRNAs. Trends Cell Biol. 2008, 18:505-516.
34. Tzur G., Israel A., Levy A., Benjamin H., Meiri E., Shufaro Y., Meir K., Khvalevsky E., Spector Y., Rojansky N., et al. Comprehensive gene and microRNA expression profiling reveals a role for microRNAs in human liver development. PLoS ONE 2009, 4:e7511.
35. Urbich C., Kuehbacher A., Dimmeler S. Role of microRNAs in vascular diseases, inflammation, and angiogenesis. Cardiovasc. Res. 2008, 79:581-588.
36. Viswanathan S.R., Daley G.Q. Lin28: A microRNA regulator with a macro role. Cell 2010, 140:445-449.
37. Zeisberg E.M., Potenta S., Xie L., Zeisberg M., Kalluri R. Discovery of endothelial to mesenchymal transition as a source for carcinoma-associated fibroblasts. Cancer Res. 2007, 67:10123-10128.
38. Zeisberg E.M., Tarnavski O., Zeisberg M., Dorfman A.L., McMullen J.R., Gustafsson E., Chandraker A., Yuan X., Pu W.T., Roberts A.B., et al. Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nat. Med. 2007, 13:952-961.
39. Zhang B., Pan X., Cobb G.P., Anderson T.A. microRNAs as oncogenes and tumor suppressors. Dev. Biol. 2007, 302:1-12.